Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-18T16:19:45.360Z Has data issue: false hasContentIssue false
  • English
  • Français

Antenatal treatment of fetal immune thrombocytopenias

Part of: Bespoke shallow archive Weizmann

Published online by Cambridge University Press:  02 April 2001

Daniel W Skupski  and
James B Bussel
Daniel W Skupski
Affiliation:
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The New York Hospital - Cornell Medical Center, New York, United States of America
James B Bussel
Affiliation:
Department of Pediatrics, Division of Pediatric Hematology/Oncology, The New York Hospital - Cornell Medical Center, New York, United States of America
Get access Rights & Permissions [Opens in a new window]

Abstract

Advances in both imaging techniques and in treatments for immune thrombocytopenias affecting the fetus have allowed for more accurate antenatal predictions of severe disease and effective antenatal treatments for those fetuses who are at risk of sequelae. This article will review current knowledge of the diagnosis and treatment of affected fetuses in alloimmune thrombocytopenia and in immune thrombocytopenic purpura.

Type
Research Article
Information
Fetal and Maternal Medicine Review , Volume 10 , Issue 1 , February 1998 , pp. 1 - 19
Copyright
© 1998 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)